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ABSTRACT
Uterine arteriovenous malformations are uncommon but potentially life-threatening conditions. They can be congenital or 
acquired and should be suspected in cases of severe or persistent uterine bleeding. In recent years, there has been an in-
creasing number of reports of acquired vascular lesions of the uterus following pregnancy, abortion, caesarean delivery and 
curettage. This paper presents the review of the literature considered epidemiology, pathophysiology, diagnostic methods 
and treatment options. Unexplained uterine bleeding should be always an indication for colour Doppler ultrasonography 
and the presence of arteriovenous malformation should be always excluded.
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INTRODUCTION
Arteriovenous malformations (AVMs) are rare but consi-
dered potentially life-threatening due to profuse or irregular 
bleeding from abnormal vascular connections [1]. The pre-
valence of uterine AVM is unknown, as only about 100 cases 
have been reported in the literature [2]. However, reported 
cases are on the rise because of the increasing availability 
of imaging modalities like ultrasound, computed tomogra-
phy (CT), and magnetic resonance imaging (MRI). Accurate 
clinical and radiological diagnosis is essential, because the 
uterine instrumentation that is often used for management 
of abnormal bleeding, can lead to massive haemorrhage. 
The initial imaging modality of choice for AVM is sonography 
with colour and spectral Doppler analysis. The diagnosis is 
based on the presence of hypoechoic sinuous spaces in the 
myometrium demonstrating vascular flow [3].
Classification and symptoms
Pregnancy-related complications are the most common 
cause of abnormal uterine bleeding in women of reproducti-
ve age. AVMs are one of the rare causes for abnormal uterine 
bleeding. They are classified into congenital and acquired, 
of which acquired AVMs are more common [1, 4]. 
Congenital AVM develop due to failure in embryological 
differentiation of primitive vascular structures, resulting in 
the creation of abnormal vascular connection [5]. Histologic 
examination of these malformations reveals many thin-
-walled capillary vessels intertwining with the vessels in the 
myometrium. Congenital AVM tend to extend beyond the 
margins of the uterus into the pelvis, with frequent feeders 
from pelvic vessels other than the uterine artery. These 
lesions have been predominantly reported in women of 
reproductive age, but very rarely in women who have never 
been pregnant [6]. Acquired AVMs are distinguished by mul-
tiple connections of varying size between the arteries and 
veins in the same proximity [6, 7]. Histologic examination 
reveals multiple small arteriovenous fistulae between the 
intramural arterial branches and the myometrial venous 
plexuses [4].
Acquired AVMs are predominantly related to various 
forms of iatrogenic uterine trauma, e.g., D&C or uterine 
surgery (cesarean section, myomectomy); even normal va-
ginal delivery could be traumatic enough to stimulate the 
formation of AVMs. Less commonly, AVMs can be triggered 
by trophoblastic disease, endometrial carcinoma, cervical 
carcinoma, and infections [1, 8, 9]. Past medical history is 
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important in patients complaining about abnormal uterine 
bleeding and may suggest the probability of uterine AVM. 
Affected patients may have a wide sp ectrum of clinical 
signs. Some patients may be asymptomatic, while others 
may present with a range of symptoms such as menor-
rhagia and menometrorrhagia after miscarriage, uterine 
surgery, or D&C; lower abdominal pain; dyspareunia; and 
anaemia [3, 10]. Severe AVM may lead to cardiovascular re-
percussions with symptoms of dyspnoea, fatigue, and heart 
decompensation [6]. In 30% of patients, blood transfusion 
is necessary [11]. 
Diagnosis
Traditionally, AVM has been diagnosed using laparo-
tomy or histopathological examination of the uterus after 
hysterectomy. The initial imaging modality of choice for 
uterine AVM is ultrasonography with colour and spectral 
Doppler analysis, which significantly increases its sensitivity. 
Visualization of the vascular nature of anechoic myometrial 
lesion is very helpful [6]. It also helps in ruling out other 
problems causing abnormal uterine bleeding like rPOC, GTD, 
sarcoma of the uterus, uterine artery pseudoaneurysm, and 
pelvic varicose veins. It has been recently suggested that 
all patients showing a hypervascular lesion in the myome-
trium must undergo a work-up for rPOC. We would like to 
focus on the fact that in normal pregnancy, due to vaso-
dilatation and decreasing resistance in the spiral arteries, 
a hypervascular appearance with turbulent flow is visible in 
the myometrium, where implantation takes place [12]. The 
hypervascularity and turbulence within the myometrium 
does not immediately disappear following spontaneous or 
induced abortion. The regression period can be prolonged 
in the presence of rPOC or molar pregnancy [13, 14]. Tim-
merman et al. describe two types of acquired uterine AVM 
following pregnancy: true AVM and subinvolution of the 
placental bed [15]. 
Ultrasonography, as a valuable, fast, easy to perform, 
cheap and non-invasive procedure, is becoming a prefer-
red method for diagnosing AVM. Grey scale ultrasound of 
uterine AVM commonly shows heterogeneous nonspecific 
spaces in the myometrium, multiple cystic lesions, and tubu-
lar anechoic areas concomitant with a normal endometrium 
[2, 16] (Fig. 1A). The most common colour Doppler imaging 
findings are reported to be hypervascularity within the 
lesion, turbulent flow, and multiple tortuous feeding ves-
sels [2] (Fig. 1B, Fig. 2). Spectral Doppler ultrasound shows 
low resistance index values and pulsatility index with high 
peak systolic velocity flow (PSV) [16]. In normal myometrium, 
the signal presents as PSV of 9–44 cm/s and RI of 0.6–0.8, 
whereas the systolic and diastolic velocities are 4 to 6 times 
higher in case of uterine AVM. Timmerman et al. showed 
that PSV could differentiate between safe and potentially 
dangerous AVM [3]. Vascular malformation with a PSV value 
of 0.83 m/s were considered potentially dangerous; these 
cases required immediate embolization. PSV values ranging 
from 0.39 to 0.83 usually indicate less dangerous vascular 
malformation. Conversely, PSV values < 0.39 m/s were la-
belled as safe [3]. Therefore, Doppler examination should 
be performed before a D&C, since this procedure in women 
with AVM is likely to worsen the bleeding. This may result 
in life-threating haemorrhage, which may also necessitate 
a hysterectomy. Furthermore, ultrasonography has been 
used to assess the effectiveness of embolization 24 hours 
after the procedure and to select the patients who require 
repeat embolization [4]. 
Digital subtraction angiography is the gold standard 
technique for diagnosing uterine AVM. Angiographic analy-
sis may reveal bilateral uterine artery hypertrophy that feed 
a tortuous, hypertrophic arterial mass with large accessory 
feeding vessels as well as early drainage into enlarged, hy-
pertrophic veins during the arterial phase [17]. This invasive 
technique allows for the confirmation of diagnosis and helps 
identify the leading feeder vessels when embolization may 
be indicated as a treatment option [18]. 
Magnetic resonance (MR) allows for the accurate diagno-
sis of AVM due to best soft tissue characterization, multipla-
nar imaging capabilities, and the use of gadolinium-based 
contrast media [19]. MRI with gadolinium contrast media 
shows a hypervascular arterial-dominant flow and allows 
Figure 1. A. Transvaginal ultrasound of bulky uterus with 
heterogeneous myometrium. Pay attention to the posterior wall 
of the uterus with an abnormal appearance of the myometrium. 
B. Ultrasound color Doppler shows increased vascularity and 
multidirectional flow within posterior wall and fundus of the uterus
A B
Figure 2. Transvaginal colour Doppler ultrasound image of multiple 
vascular channels within myometrium showing colored mosaic 
pattern which may suggest arteriovenous malformation
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for the accurate evaluation of vascular supply and drainage. 
Typical features of the AVM in MRI include a bulky uterus, 
with a focal mass, disruption of the junctional zones, multi-
ple serpiginous flow-related signal voids in the myometrium 
with intense enhancement in post-contrast images, and 
prominent parametrial vessels [17, 20]. MRI also provides 
detailed visualization of the anatomy and the relation of 
the AVM with the surrounding structures [20]. The main 
disadvantages of MRI are its high cost, limited availability in 
some countries, and relatively long time of acquisition (e.g. 
when compared to CT angiography). 
The role of three-dimensional CT is to define the extent 
of involvement, to rule out extrauterine involvement, to 
differentiate between congenital and acquired uterine AVM, 
and to identify the feeding vessels or uterine arteries [7, 21]. 
CT angiography reduces the radiation dose, study time, 
and contrast required to perform the procedure in patients 
planned for embolization. In patients scheduled to undergo 
surgery, it could be useful for orient the surgeon to the ana-
tomy [22]. CT angiography is preferred in unstable patients 
with heavy bleeding or those who have contraindications 
for undergoing MRI [7]. 
Hysteroscopy has also been used to diagnose AVM, but 
its value is limited [11]. However, it could be valuable for AVM 
diagnosis that it is localized just beneath the endometrium.
Nowadays, angiography is usually used for planned 
therapeutic embolization or before surgical management, 
whereas ultrasound examination is becoming a preferred 
diagnostic tool for AVM. Many authors do not recommend 
performing angiography in all patients with a hypervascular 
uterine lesion as a rule [23]. 
Treatment
Since most women with AVM are of childbearing age 
and present with coexisting excessive vaginal bleeding, it 
is difficult to propose the appropriate treatment. 
Uterine artery embolization is considered the first line 
treatment for women with recurrent episodes of bleeding, 
with severe bleeding or for hemodynamically unstable 
patients who wish to preserve fertility [15, 24]. The eligi-
bility of patients for embolization is based on the clinical 
condition; the size of the AVM in imaging studies does not 
correlate with the need for embolization. This procedure is 
highly effective, safe, and has a low risk of complications; 
however, some cases may require to repeat embolization 
[2, 17, 24, 25]. The possible side effects are low-grade fever, 
pain, infection, transient buttock and lower limb claudica-
tion, perineal skin sloughing, uterovaginal and recto-vesi-
co-vaginal fistulae, and urinary bladder necrosis [26–28]. 
However, the risk of complications is extremely rare and is 
minimized when the procedure is performed by an inte-
rventional radiology expert. Embolization does not affect 
the menstrual cycle or pregnancy. Poppe et al. showed 
normal placental flow on Doppler ultrasound examination 
in pregnant patients who had previously undergone pe-
lvic embolization [29]. There are no reports of infertility or 
intrauterine growth restriction following this procedure. It 
is estimated that uterine AVM has been linked to recurrent 
pregnancy loss, because of the hypervascularization that 
may alter the implantation site of the embryo [30]. Owing 
to the fact that uterine AVMs have a tendency to proliferate 
during pregnancy, some authors consider the presence of 
uterine AVM an absolute contraindication for pregnancy 
[17]. Therefore, young women, who wish to preserve fertility, 
should be treated by means of angiographic embolization. 
Various agents such as coils, gelatine sponge, polyvinyl 
alcohol, detachable balloons, and isobutyl-2-cyanoacrylate 
have been used for uterine artery embolization; the choice 
of agent depends on the vessel dimension that needs to 
be embolized and by whether temporary or permanent 
occlusion is required [31]. Nowadays, absorbable gelatine 
sponge pledgets are the material of choice for uterine artery 
embolization [31]. Uterine artery embolization is the gold 
standard treatment for curing haemorrhage due to AVM in 
hemodynamically stable patients. 
Hysterectomy remains the treatment of choice in post-
menopausal women with AVM, in women who do not wish 
to preserve fertility, as an emergency procedure in life-
-threating conditions, or when transcatheter embolization 
fails  [18]. Intrauterine tamponade with a Foley catheter 
should also be considered in life-threating haemorrhage [4]. 
Expectant management, oestrogens and progestins, 
methylergonovine, danazol, 15-methyl-prostaglandin F2al-
pha, oral contraceptive pills, intramuscular and subsequent 
oral methylergonovine maleate, intravenous conjugated 
oestrogens with oral methylergometrine maleate, and in-
trauterine contraceptive devices have been found to be 
useful in hemodynamically stable patients with single or 
few episodes of vaginal bleeding and have shown to be 
associated with regression of lesions, based on ultrasound 
examination [11, 15, 32, 33].
There are other less frequently used surgical methods, 
such as the coagulation of AVM under hysteroscopic gu-
idance, laparoscopic bipolar coagulation of uterine vessels, 
surgical removal of the AVM, and uterine artery ligation 
[9, 11, 34]. Because of the risk of spontaneous rupture of 
the subserosal type uterine AVM, some authors indicate 
the surgical removal of this type of lesion as a treatment 
of choice [35]. 
CONCLUSIONS
Unexplained uterine bleeding should be always an in-
dication for colour Doppler ultrasonography. Vascular le-
sions of the uterus may be more common than formerly 
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thought. Usually, AVMs are present in young women, with 
a previous history of spontaneous abortion with D&C of 
the uterus. Definitely, three-dimensional CT angiography 
helps in confirming the diagnosis. In some cases of AVMs 
uterine artery embolization is effective in treatment. Care 
must be taken while diagnosing AVM after miscarriage. 
These patients should be first evaluated for rPOC with mo-
nitoring of beta-hCG levels but the presence of AVM should 
be always excluded
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